This work elucidates the effects of Bay 1000394, a CDK-Inhibitor, on primary CLL cells utilizing flow cytometry assays (Annexin-V-Assay, DiOC6-Staining ΔΨm, Tunel-Assay), and immunoblotting techniques. We analyze the effects of Bay 1000394 on resting CLL cells and on proliferating CLL cells stimulated with IL-2 and CpG oligonucleotides in an in vitro stimulation model. Additionally, we analyze the impact of interactions of CLL cells in the presence of supportive stroma on the effects of programmed cell death mediation for Bay 1000394. The results show that nanomolar concentrations of Bay 1000394 are highly effective in inducing apoptosis within a large proportion of resting, proliferating and stromal supported CLL cells. Interestingly we also detect caspase independent forms of programmed cell death different from necroptosis.
«
This work elucidates the effects of Bay 1000394, a CDK-Inhibitor, on primary CLL cells utilizing flow cytometry assays (Annexin-V-Assay, DiOC6-Staining ΔΨm, Tunel-Assay), and immunoblotting techniques. We analyze the effects of Bay 1000394 on resting CLL cells and on proliferating CLL cells stimulated with IL-2 and CpG oligonucleotides in an in vitro stimulation model. Additionally, we analyze the impact of interactions of CLL cells in the presence of supportive stroma on the effects of programm...
»